A. Amadi

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Bristol-Myers Squibb (United Kingdom)(Current)

A. Amadi is an author at Bristol-Myers Squibb (United Kingdom) specializing in treatment cost analysis, markov cost-effectiveness models, and melanoma immunotherapy.

Publications per year

2018–2018

Publications

Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England

Dawn Lee, A. Amadi, Javier Sabater et al. · PharmacoEconomics - Open · 2018 · 20 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

1–1 of 1